{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:01:16Z","timestamp":1791601276682,"version":"4.3.4"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110394","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:57:03Z","timestamp":1787065023000},"page":"110394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Glycine-conjugated coumarin\u2013quinazoline hybrids as potent anticancer agents: synthesis, cytotoxicity, SAR and molecular docking studies"],"prefix":"10.1016","volume":"181","author":[{"given":"Nedime","family":"\u00c7al\u0131\u015fkan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Emirik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozan Emre","family":"Ey\u00fcpo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Mente\u015fe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110394_bb0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12039-018-1523-3","article-title":"Synthesis and biological evaluation of novel benzothiophene derivatives","volume":"130","author":"Algso","year":"2018","journal-title":"J. Chem. Sci."},{"key":"10.1016\/j.bioorg.2026.110394_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113543","article-title":"Design and synthesis of novel benzothiophene analogs as selective estrogen receptor covalent antagonists against breast cancer","volume":"221","author":"Bai","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17050864","article-title":"Lifestyle, environmental, occupational, and dietary risk factors in small-cell vs. non-small-cell advanced lung cancer patients: is there a connection?","volume":"17","author":"Jovi\u010di\u0107-Bata","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2026.110394_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-26721-7","article-title":"Biological evaluations and biomolecular interactions along with computational insights of arylidene isatin hydrazones synthesized using nanocatalyst","volume":"15","author":"Feizi-Dehnayebi","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110394_bb0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41571-023-00844-0","article-title":"Lung cancer in patients who have never smoked \u2014 an emerging disease","volume":"21","author":"LoPiccolo","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.110394_bb0030","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jtho.2023.05.024","article-title":"Air pollution and lung cancer: a review by international association for the study of lung cancer early detection and screening committee","volume":"18","author":"Berg","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bioorg.2026.110394_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ph18121899","article-title":"Evaluation of antiproliferative activity and molecular modeling studies of some novel benzimidazolone-bridged hybrid compounds","volume":"18","author":"G\u00fcven","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110394_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5114\/wo.2021.103829","article-title":"Epidemiology of lung cancer","volume":"25","author":"Chaitanya Thandra","year":"2021","journal-title":"Wsp\u00f3\u0142czesna Onkologia"},{"key":"10.1016\/j.bioorg.2026.110394_bb0045","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","article-title":"Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy","volume":"16","author":"Zafar","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bioorg.2026.110394_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117535","article-title":"Mechanistic study of cancer drug delivery: current techniques, limitations, and future prospects","volume":"290","author":"Imtiaz","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0055","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/ijc.33417","article-title":"Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017","volume":"148","author":"van der Meer","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2026.110394_bb0060","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/cac2.12207","article-title":"Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020","volume":"41","author":"Lei","year":"2021","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bioorg.2026.110394_bb0065","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bioorg.2026.110394_bb0070","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/cancers12051172","article-title":"Inducing angiogenesis, a key step in Cancer vascularization, and treatment approaches","volume":"12","author":"Saman","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2026.110394_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2025.127475","article-title":"Probing the biological activity of isatin derivatives against human lung cancer A549 cells: cytotoxicity, CT-DNA\/BSA binding, DFT\/TD-DFT, topology, ADME-Tox, docking and dynamic simulations","volume":"428","author":"Feizi-Dehnayebi","year":"2025","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioorg.2026.110394_bb0080","doi-asserted-by":"crossref","DOI":"10.1134\/S1068162025603118","article-title":"New 1,3-benzoxazol-2(3H)-one aroylhydrazone and acetamide hybrids as promising acetylcholinesterase inhibitors: microwave synthesis, structure\u2013activity relationship, and drug-likeness evaluation","volume":"52","author":"Yilmaz","year":"2026","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0085","doi-asserted-by":"crossref","DOI":"10.2174\/0115701794455220260217073726","article-title":"Benzimidazolone bridged triheterocyclic compounds as urease and lipase inhibitors: a study on design, synthesis, molecular docking, and structure activity relationship (SAR) studies","volume":"23","author":"G\u00fcven","year":"2026","journal-title":"Curr. Org. Synth."},{"key":"10.1016\/j.bioorg.2026.110394_bb0090","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/bioengineering12040341","article-title":"Current research in drug-free cancer therapies","volume":"12","author":"Andavar","year":"2025","journal-title":"Bioengineering"},{"key":"10.1016\/j.bioorg.2026.110394_bb0095","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110394_bb0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/10426507.2024.2333471","article-title":"A facile ultrasonic synthesis approach to 3-H-quinazolinethione derivatives and their urease inhibition studies","volume":"199","author":"\u00c7al\u0131\u015fkan","year":"2024","journal-title":"Phosphorus Sulfur Silicon Relat. Elem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0105","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The Lancet Commission on prostate cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2026.110394_bb0110","doi-asserted-by":"crossref","first-page":"12673","DOI":"10.1007\/s00210-026-05206-y","article-title":"Dual inhibition of cell cycle progression and apoptotic resistance in breast cancer by novel benzimidazole-based therapeutics","volume":"399","author":"Keser","year":"2026","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110394_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202501775","article-title":"Design, synthesis, and molecular docking of triazole-coumarin hybrids as potent breast Cancer inhibitors targeting cell cycle and apoptosis","author":"Keser","year":"2025","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2026.110394_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70267","article-title":"Synthesis, characterization, and biological evaluation of aliphatic-substituted benzimidazole derivatives: induction of apoptosis, cell cycle arrest, and molecular docking in breast cancer cells","volume":"87","author":"Keser","year":"2026","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2026.110394_bb0125","doi-asserted-by":"crossref","DOI":"10.1007\/s11010-026-05600-3","article-title":"Synthesis and multilevel evaluation of benzimidazole-based anticancer compounds: DNA\/serum albumin interaction, and in-depth theoretical insights","author":"Kundu","year":"2026","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0130","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2174\/1871520615666150101125503","article-title":"Coumarin: a promising scaffold for anticancer agents","volume":"15","author":"Kaur","year":"2015","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1039\/D3MD00511A","article-title":"Latest developments in coumarin-based anticancer agents: mechanism of action and structure\u2013activity relationship studies","volume":"15","author":"Koley","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0140","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ejmech.2014.02.026","article-title":"Anticancer activity of new coumarin substituted hydrazide\u2013hydrazone derivatives","volume":"76","author":"Nasr","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/scipharm91020018","article-title":"Medicinal chemistry of quinazolines as anticancer agents targeting tyrosine kinases","volume":"91","author":"Zayed","year":"2023","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.bioorg.2026.110394_bb0150","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s11094-025-03344-w","article-title":"Biscoumarin derivatives bridged quinazolinedion: synthesis, molecular docking study, and cytotoxic activities","volume":"58","author":"Aky\u00fcz","year":"2025","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.bioorg.2026.110394_bb0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1752-153X-7-95","article-title":"Quinazoline derivatives: synthesis and bioactivities","volume":"7","author":"Wang","year":"2013","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.bioorg.2026.110394_bb0160","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3109\/14756366.2011.601302","article-title":"Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents","volume":"27","author":"Alafeefy","year":"2012","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0165","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3390\/ph18111627","article-title":"Synthesis and anticancer evaluation of some glycine conjugated hybrid compounds containing coumarin, thiophene and quinazoline moieties","volume":"18","author":"\u00c7al\u0131\u015fkan","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110394_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128531","article-title":"Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: modification of the benzenoid part","volume":"59","author":"Megahed","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110394_bb0175","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1134\/S1068162023030044","article-title":"Design, synthesis, and anticancer activity of new quinazoline derivatives containing acetylhydrazide moiety as EGFR inhibitors and apoptosis inducers","volume":"49","author":"Alsantali","year":"2023","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0180","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1134\/S1068162024010126","article-title":"Synthesis and biological evaluation of coumarin-amino acid-benzotriazole conjugates","volume":"50","author":"Mente\u015fe","year":"2024","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0185","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.bmc.2007.10.012","article-title":"Synthesis, DNA binding, and cytotoxicity of 1,4-bis(2-amino-ethylamino)anthraquinone\u2013amino acid conjugates","volume":"16","author":"Hsin","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0190","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2147\/DDDT.S297013","article-title":"Amino acid conjugates of aminothiazole and aminopyridine as potential anticancer agents: synthesis, molecular docking and in vitro evaluation","volume":"15","author":"Naz","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bioorg.2026.110394_bb0195","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.3390\/ijms25042121","article-title":"Evaluation of antitumor activity of xanthones conjugated with amino acids","volume":"25","author":"Barbosa","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110394_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071959","article-title":"Coumarins and coumarin-related compounds in pharmacotherapy of cancer","volume":"12","author":"K\u00fcpeli Akkol","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2026.110394_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111587","article-title":"Coumarin-containing hybrids and their anticancer activities","volume":"181","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0210","article-title":"Coumarin-heterocycle framework: a privileged approach in promising anticancer drug design","volume":"2","author":"Dorababu","year":"2021","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"10.1016\/j.bioorg.2026.110394_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.142149","article-title":"Coumarin-based hybrid compounds: a new approach to cancer therapy","volume":"1337","author":"Kumari","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110394_bb0220","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1134\/S1068162022040033","article-title":"Discovery of new quinazoline-based anticancer agents as VEGFR-2 inhibitors and apoptosis inducers","volume":"48","author":"Ahmed","year":"2022","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0225","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1007\/s13738-024-03080-0","article-title":"Synthesis of novel quinazolinone-triheterocyclic hybrides as dual inhibition of urease and ache","volume":"21","author":"Mente\u015fe","year":"2024","journal-title":"J. Iran. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110394_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201800182","article-title":"Synthesis of some novel quinazolin-4(3H)-one hybrid molecules as potent urease inhibitors","volume":"351","author":"Mente\u015fe","year":"2018","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2026.110394_bb0235","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s10593-017-2002-3","article-title":"Synthesis and evaluation of \u03b1-glucosidase and pancreatic lipase inhibition by quinazolinone-coumarin hybrids","volume":"52","author":"Mente\u015fe","year":"2016","journal-title":"Chem. Heterocycl. Compd."},{"key":"10.1016\/j.bioorg.2026.110394_bb0240","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bioorg.2018.06.011","article-title":"Synthesis and molecular docking study of some novel 2,3-disubstituted quinazolin-4(3H)-one derivatives as potent inhibitors of urease","volume":"80","author":"Aky\u00fcz","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0245","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1002\/jhet.3703","article-title":"Synthesis of novel 2,3-disubstituted quinazolin-4(3H)-one derivatives containing hydrazone skeleton as potent urease inhibitors and their antimicrobial activities","volume":"56","author":"Aky\u00fcz","year":"2019","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0250","doi-asserted-by":"crossref","first-page":"14418","DOI":"10.1021\/acs.joc.4c01834","article-title":"Mn-catalyzed electrooxidative radical Cascade cyclization for the synthesis of 6-phosphorylated Quinoxalino[2,1-b]quinazolin-12-ones","volume":"89","author":"Xie","year":"2024","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100216","article-title":"Design, synthesis, and evaluation of novel (E)- N \u2019-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides as antitumor agents","volume":"355","author":"Dung","year":"2022","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2026.110394_bb0260","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1134\/S1070428024050142","article-title":"Synthesis and anticancer activities of amide-bridged coumarin\u2013quinazolinone hybrid compounds","volume":"60","author":"\u00c7ali\u015fkan","year":"2024","journal-title":"Russ. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ardp.201600369","article-title":"Design, synthesis, and biological evaluation of coumarin\u2013triazole hybrid molecules as potential antitumor and pancreatic lipase agents","volume":"350","author":"Kahveci","year":"2017","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2026.110394_bb0270","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/nprot.2006.238","article-title":"Analysis of apoptosis by propidium iodide staining and flow cytometry","volume":"1","author":"Riccardi","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioorg.2026.110394_bb0275","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","article-title":"A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V","volume":"184","author":"Vermes","year":"1995","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2026.110394_bb0280","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-1759(88)90310-9","article-title":"A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity","volume":"115","author":"Decker","year":"1988","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2026.110394_bb0285","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70944","article-title":"Design, synthesis, and biological evaluation of novel quinazoline\u2013thiazole hybrids as potential anticancer agents","volume":"40","author":"Gomha","year":"2026","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bioorg.2026.110394_bb0290","doi-asserted-by":"crossref","first-page":"67754","DOI":"10.18632\/oncotarget.18834","article-title":"Cell cycle perturbation induced by gemcitabine in human tumor cells in cell culture, xenografts and bladder cancer patients: implications for clinical trial designs combining gemcitabine with a Chk1 inhibitor","volume":"8","author":"Montano","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2026.110394_bb0295","doi-asserted-by":"crossref","first-page":"C281","DOI":"10.1152\/ajpcell.00422.2003","article-title":"G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K\/AKT\/mTOR\/p70S6K1 signaling in human ovarian cancer cells","volume":"287","author":"Gao","year":"2004","journal-title":"Am. J. Phys. Cell Physiol."},{"key":"10.1016\/j.bioorg.2026.110394_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27104485","article-title":"Synthesis and biological evaluation of new quinazolin-4(3H)-one\u2013coumarin hybrids designed as anticancer and antibacterial agents","volume":"27","author":"Paramonova","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110394_bb0305","doi-asserted-by":"crossref","first-page":"24671","DOI":"10.1039\/D4RA04226C","article-title":"Coumarin\u2013amino acid hybrids as promising anticancer agents: design, synthesis, docking studies and CK2 inhibition","volume":"14","author":"El-Etrawy","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110394_bb0310","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hlca.19850680410","article-title":"Chinazolincarbons\u00e4uren. VII. Mitteilung. Ein einfacher Zugang zu (4-Oxo-3,4-dihydrochinazolin-3-yl)-alkans\u00e4uren, (4-Oxo-3,4-dihydro-1,2,3-benzotriazin-3-yl)-alkans\u00e4uren und deren Estern","volume":"68","author":"S\u00fcsse","year":"1985","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.bioorg.2026.110394_bb0315","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10593-015-1714-5","article-title":"Microwave-assisted synthesis of some new coumarin derivatives including 1,2,4-triazol-3-one and investigation of their biological activities","volume":"51","author":"Kahveci","year":"2015","journal-title":"Chem. Heterocycl. Compd. (N. Y)."},{"key":"10.1016\/j.bioorg.2026.110394_bb0320","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/jhet.4165","article-title":"Synthesis and biological evaluation of some 1,3-benzoxazol-2(3H)-one hybrid molecules as potential antioxidant and urease inhibitors","volume":"58","author":"Yilmaz","year":"2020","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0325","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0030-1258345","article-title":"Novel fluorescent aminoxy acids and aminoxy hybrid peptides","volume":"2011","author":"Katritzky","year":"2011","journal-title":"Synthesis-Stuttgart"},{"key":"10.1016\/j.bioorg.2026.110394_bb0330","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2026.110394_bb0335","series-title":"Checkpoint Controls and Cancer","first-page":"301","article-title":"Analysis of cell cycle by flow cytometry","author":"Pozarowski","year":"2004"},{"key":"10.1016\/j.bioorg.2026.110394_bb0340","series-title":"Schr\u00f6dinger Release 2023: Maestro","year":"2023"},{"key":"10.1016\/j.bioorg.2026.110394_bb0345","series-title":"Schr\u00f6dinger Release 2023: LigPrep","year":"2023"},{"key":"10.1016\/j.bioorg.2026.110394_bb0350","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bioorg.2026.110394_bb0355","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK a prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2026.110394_bb0360","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s42003-022-03516-4","article-title":"TAS1553, a small molecule subunit interaction inhibitor of ribonucleotide reductase, exhibits antitumor activity by causing DNA replication stress","volume":"5","author":"Ueno","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bioorg.2026.110394_bb0365","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1097-2765(05)00089-4","article-title":"Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine","volume":"6","author":"Walker","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2026.110394_bb0370","doi-asserted-by":"crossref","first-page":"16589","DOI":"10.1021\/acs.jmedchem.2c01422","article-title":"Discovery of GDC-0077 (inavolisib), a highly selective inhibitor and degrader of mutant PI3K\u03b1","volume":"65","author":"Hanan","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110394_bb0375","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2026.110394_bb0380","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/ct100578z","article-title":"PROPKA3: consistent treatment of internal and surface residues in empirical p K a predictions","volume":"7","author":"Olsson","year":"2011","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bioorg.2026.110394_bb0385","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:14:17Z","timestamp":1791407657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826009302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":77,"alternative-id":["S0045206826009302"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110394","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycine-conjugated coumarin\u2013quinazoline hybrids as potent anticancer agents: synthesis, cytotoxicity, SAR and molecular docking studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110394"}}